Literature DB >> 19710451

Inflammatory regulation by TLR3 in acute hepatitis.

Xiaoyan Xiao1, Peng Zhao, Daniel Rodriguez-Pinto, Dake Qi, Octavian Henegariu, Lena Alexopoulou, Richard A Flavell, F Susan Wong, Li Wen.   

Abstract

TLR3 is known to respond to dsRNA from viruses, apoptotic cells, and/or necrotic cells. Dying cells are a rich source of ligands that can activate TLRs, such as TLR3. TLR3 expressed in the liver is likely to be a mediator of innate activation and inflammation in the liver. The importance of this function of TLR3 during acute hepatitis has not previously been fully explored. We used the mouse model of Con A-induced hepatitis and observed a novel role for TLR3 in hepatocyte damage in the absence of an exogenous viral stimulus. Interestingly, TLR3 expression in liver mononuclear cells and sinus endothelial cells was up-regulated after Con A injection and TLR3(-/-) mice were protected from Con A-induced hepatitis. Moreover, splenocytes from TLR3(-/-) mice proliferated less to Con A stimulation in the presence of RNA derived from damaged liver tissue compared with wild-type (WT) mice. To determine the relative contribution of TLR3 expression by hematopoietic cells or nonhematopoietic to liver damage during Con A-induced hepatitis, we generated bone marrow chimeric mice. TLR3(-/-) mice engrafted with WT hematopoietic cells were protected in a similar manner to WT mice reconstituted with TLR3(-/-) bone marrow, indicating that TLR3 signaling in both nonhematopoietic and hematopoietic cells plays an important role in mediating liver damage. In summary, our data suggest that TLR3 signaling is necessary for Con A-induced liver damage in vivo and that TLR3 regulates inflammation and the adaptive T cell immune response in the absence of viral infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19710451      PMCID: PMC3787866          DOI: 10.4049/jimmunol.0901221

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  Nod-like proteins in immunity, inflammation and disease.

Authors:  Jörg H Fritz; Richard L Ferrero; Dana J Philpott; Stephen E Girardin
Journal:  Nat Immunol       Date:  2006-12       Impact factor: 25.606

Review 2.  Intracellular NOD-like receptors in host defense and disease.

Authors:  Thirumala-Devi Kanneganti; Mohamed Lamkanfi; Gabriel Núñez
Journal:  Immunity       Date:  2007-10       Impact factor: 31.745

Review 3.  Liver: An organ with predominant innate immunity.

Authors:  Bin Gao; Won-Il Jeong; Zhigang Tian
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

Review 4.  The NOD mouse as a model of SLE.

Authors:  P A Silveira; A G Baxter
Journal:  Autoimmunity       Date:  2001       Impact factor: 2.815

Review 5.  Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity.

Authors:  L Wen; Y Ma; D P Bogdanos; F S Wong; A Demaine; G Mieli-Vergani; D Vergani
Journal:  Curr Mol Med       Date:  2001-07       Impact factor: 2.222

6.  IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1.

Authors:  Barbara Jaruga; Feng Hong; Won-Ho Kim; Bin Gao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-07-08       Impact factor: 4.052

7.  mRNA is an endogenous ligand for Toll-like receptor 3.

Authors:  Katalin Karikó; Houping Ni; John Capodici; Marc Lamphier; Drew Weissman
Journal:  J Biol Chem       Date:  2004-01-16       Impact factor: 5.157

Review 8.  Fulminant liver disease.

Authors:  Frank Vinholt Schiødt; William M Lee
Journal:  Clin Liver Dis       Date:  2003-05       Impact factor: 6.126

9.  TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells.

Authors:  Wei Jiang; Rui Sun; Rongbin Zhou; Haiming Wei; Zhigang Tian
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

10.  Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis.

Authors:  Takehiro Torisu; Mako Nakaya; Satoko Watanabe; Masayuki Hashimoto; Hideyuki Yoshida; Takatoshi Chinen; Ryoko Yoshida; Fuyuki Okamoto; Toshikatsu Hanada; Kumiko Torisu; Giichi Takaesu; Takashi Kobayashi; Hideo Yasukawa; Akihiko Yoshimura
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

View more
  15 in total

1.  Increased expression of endosomal members of toll-like receptor family abrogates wound healing in patients with type 2 diabetes mellitus.

Authors:  Kanhaiya Singh; Neeraj K Agrawal; Sanjeev K Gupta; Gyanendra Mohan; Sunanda Chaturvedi; Kiran Singh
Journal:  Int Wound J       Date:  2015-01-14       Impact factor: 3.315

2.  Association of Toll-Like Receptor 3 and Toll-Like Receptor 9 Single Nucleotide Polymorphisms with Hepatitis C Virus Infection and Hepatic Fibrosis in Egyptian Patients.

Authors:  Rania A Zayed; Dalia Omran; Doha A Mokhtar; Zinab Zakaria; Sameera Ezzat; Mohamed A Soliman; Lamiaa Mobarak; Hossam El-Sweesy; Ghada Emam
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

Review 3.  IL-33/ST2 axis in inflammation and immunopathology.

Authors:  Marija Milovanovic; Vladislav Volarevic; Gordana Radosavljevic; Ivan Jovanovic; Nada Pejnovic; Nebojsa Arsenijevic; Miodrag L Lukic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

4.  Mincle Signaling Promotes Con A Hepatitis.

Authors:  Stephanie H Greco; Alejandro Torres-Hernandez; Aleksandr Kalabin; Clint Whiteman; Rae Rokosh; Sushma Ravirala; Atsuo Ochi; Johana Gutierrez; Muhammad Atif Salyana; Vishnu R Mani; Savitha V Nagaraj; Michael Deutsch; Lena Seifert; Donnele Daley; Rocky Barilla; Mautin Hundeyin; Yuriy Nikifrov; Karla Tejada; Bruce E Gelb; Steven C Katz; George Miller
Journal:  J Immunol       Date:  2016-08-24       Impact factor: 5.422

Review 5.  The roles of Galectin-3 in autoimmunity and tumor progression.

Authors:  Gordana Radosavljevic; Vladislav Volarevic; Ivan Jovanovic; Marija Milovanovic; Nada Pejnovic; Nebojsa Arsenijevic; Daniel K Hsu; Miodrag L Lukic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

6.  Central role of the TIR-domain-containing adaptor-inducing interferon-β (TRIF) adaptor protein in murine sterile liver injury.

Authors:  Katherine J Brempelis; Sebastian Y Yuen; Nicole Schwarz; Isaac Mohar; Ian N Crispe
Journal:  Hepatology       Date:  2017-03-03       Impact factor: 17.425

7.  Quercetin Protects Mice from ConA-Induced Hepatitis by Inhibiting HMGB1-TLR Expression and Down-Regulating the Nuclear Factor Kappa B Pathway.

Authors:  Xi Li; Hong-Chun Liu; Qun-Yan Yao; Bei-Li Xu; Shun-Cai Zhang; Chuan-Tao Tu
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

8.  Interferon β (IFN-β) Production during the Double-stranded RNA (dsRNA) Response in Hepatocytes Involves Coordinated and Feedforward Signaling through Toll-like Receptor 3 (TLR3), RNA-dependent Protein Kinase (PKR), Inducible Nitric Oxide Synthase (iNOS), and Src Protein.

Authors:  Liyong Zhang; Wenpei Xiang; Guoliang Wang; Zhengzheng Yan; Zhaowei Zhu; Zhong Guo; Rajib Sengupta; Alex F Chen; Patricia A Loughran; Ben Lu; Qingde Wang; Timothy R Billiar
Journal:  J Biol Chem       Date:  2016-05-17       Impact factor: 5.157

9.  The great escape: microbiotal LPS takes a toll on the liver.

Authors:  David S Weiss
Journal:  Cancer Prev Res (Phila)       Date:  2012-09

10.  Integrated intra- and intercellular signaling knowledge for multicellular omics analysis.

Authors:  Dénes Türei; Alberto Valdeolivas; Lejla Gul; Nicolàs Palacio-Escat; Michal Klein; Olga Ivanova; Márton Ölbei; Attila Gábor; Fabian Theis; Dezső Módos; Tamás Korcsmáros; Julio Saez-Rodriguez
Journal:  Mol Syst Biol       Date:  2021-03       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.